Viewing nowCombinationIlsung Ezetimibe Atorvastatin Calcium Trihydrate Tablet 10/10 mg
Atorvastatin Calcium Trihydrate 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.

MFDS item code 202101655 · Approved 2021.02.18 · Insurance code 655404170
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This drug is used to improve cholesterol and triglyceride levels in patients with hypercholesterolemia and dyslipidemia. It is administered as an adjunct to dietary therapy to reduce total cholesterol, LDL cholesterol, apo B, triglycerides, and non-HDL cholesterol, and to increase HDL cholesterol, particularly in patients with primary hypercholesterolemia. It is used as an adjunctive therapy in patients with homozygous familial hypercholesterolemia when other treatments are ineffective. This drug should be used with appropriate dietary therapy considering various risk factors, and it is important to identify and treat secondary causes of dyslipidemia. It is effective in reducing the risk of cardiovascular disease and improving cholesterol control.
This medicine is administered once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/10mg∼10/80mg once daily. The recommended initial dosage is 10/10mg or 10/20mg once daily. For patients who require greater LDL cholesterol reduction (55% or more), the recommended initial dosage is 10/40mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dosage for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful.
This drug helps reduce blood cholesterol levels by inhibiting cholesterol production in the liver. Muscle problems may arise, so if symptoms such as muscle pain, muscle weakness, or muscle cramps occur, patients should immediately inform their doctor. Particularly, patients at risk for severe myopathy or rhabdomyolysis should discontinue or temporarily pause the use of this drug. Since it may affect liver function, patients should undergo liver function tests before administration and regularly monitor liver function during treatment. If symptoms of liver damage such as jaundice, nausea, vomiting, or fatigue occur, patients should consult healthcare professionals immediately. This drug is not to be administered to patients with certain liver diseases or those with abnormally high liver enzyme levels. Women who are pregnant or may become pregnant, and nursing mothers should not take this drug. Appropriate contraception should be used, and if pregnancy is confirmed, the drug should be discontinued immediately. Elderly patients, those with impaired kidney function, patients with hypothyroidism, and those with a history of muscle disease should use this drug cautiously. This drug may interact with various other medications, especially those metabolized in the liver or those that may cause muscle toxicity, so caution is necessary if taken in conjunction. Patients must inform their doctor or pharmacist of any currently taken medications. During treatment, side effects such as dizziness, headaches, indigestion, abdominal pain, and diarrhea may occur, so it is important to monitor bodily condition closely. In cases of overdose, as there is no specific antidote, patients should receive appropriate treatment and supportive care based on symptoms, and liver function and muscle enzyme tests should be conducted. Safety and efficacy in children have not been established, thus use is not recommended. This drug should be stored out of the reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container to prevent exposure to air and moisture, and it is safe to store at room temperature between 1 to 30 degrees Celsius. Storing it this way preserves the drug's effectiveness and prevents degradation.
White or off-white oblong film-coated tablet
Alu-Alu - 30 tablets/box [(10 tablets/Alu-Alu*3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium Trihydrate 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.